Neurogene, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US64135M1053
USD
20.55
1.27 (6.59%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryNeurogene, Inc. VS Pharmaceuticals & Biotechnology
 
1D
6.59%
0.88%
1W
-1.77%
0.1%
1M
-2.1%
2.9%
YTD
-10.1%
16.2%
1Y
-6.91%
16.49%
3Y
131.94%
79.02%
5Y
-91.05%
84.25%
10Y
-91.05%
240.78%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
19.48%
0%
19.48%
6 Months
12.3%
0%
12.3%
1 Year
-6.91%
0%
-6.91%
2 Years
36.09%
0%
36.09%
3 Years
131.94%
0%
131.94%
4 Years
-79.77%
0%
-79.77%
5 Years
-91.05%
0%
-91.05%

Neurogene, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary